ETHOS Health Communications changes name to PRECISIONscientia

 

 

ETHOS Health Communications, a Pennsylvania-based medical communications agency specializing in interpreting and communicating the science and data for cutting-edge therapies, has a new name, PRECISIONscientia. Management says the name change, which was a year in the making, reflects the company’s long-term commitment to communicating the science of medicine with accuracy and clarity, and fully aligns the firm within Precision Value & Health (PV&H), a Precision Medicine Group business.

Scientia, defined in Latin as knowledge – particularly knowledge based on demonstrable and reproducible data – conveys the team’s deep scientific expertise and profound responsibility to effectively translate and communicate clinical data in order to advance medicine and improve human health. “In today’s complex environment, communicating important science with accuracy and clarity is critical,” management says.

In addition to the name change, long-term leader Nate Wible was promoted to executive VP and managing director of PRECISIONscientia, as ETHOS co-founder and president, Anita O’Connor, retires.

“We became part of the Precision family in June 2018 and have spent the last year preparing to take this critical step in making the partnership clearer to our clients and to the market,” Wible says. “While the timing of our name change is not ideal given current events, we believe that moving forward reflects our commitment to ensuring continued business operations and seamless support of our clients, as we collectively work to improve the care and outcomes of patients.”

According to agency executives, since its founding in 2002, PRECISIONscientia has helped pharma and biotech companies successfully bring novel therapies to market in the most complex areas of medicine, including gene therapy, CAR T-cell therapy, and rare diseases. Managers say one of the many key differentiators that sets PRECISIONscientia apart from competitors is i\the agency’s ability to dedicate scientists and doctoral-level medical professionals to its clients’ businesses throughout the commercialization process. “This unparalleled depth of knowledge and expertise allows the company to understand how best to deliver critical information to key audiences throughout the commercialization journey, including healthcare providers, caregivers, and the world at large,” agency executives say.

“Although PRECISIONscientia has been a part of the family now for over 18 months, we are thrilled that this name change formally aligns it with PV&H,” says Carolyn Morgan, who oversees the HCP, patient, and consumer service offerings for Precision Value & Health. “This effort further underscores our commitment to bring together best-of-class teams to deliver seamless service to clients along the continuum of the drug development and commercialization journey.”